Allison Eddy
Last active: 2/3/2012


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Mannose receptor 2 attenuates renal fibrosis. López-Guisa JM, Cai X, Collins SJ, Yamaguchi I, Okamura DM, Bugge TH, Isacke CM, Emson CL, Turner SM, Shankland SJ, Eddy AA (2012) J Am Soc Nephrol 23(2): 236-51
    › Primary publication · 22095946 (PubMed) · PMC3269177 (PubMed Central)
  2. Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Okamura DM, Pasichnyk K, Lopez-Guisa JM, Collins S, Hsu DK, Liu FT, Eddy AA (2011) Am J Physiol Renal Physiol 300(1): F245-53
    › Primary publication · 20962111 (PubMed) · PMC3023228 (PubMed Central)
  3. CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. Okamura DM, Pennathur S, Pasichnyk K, López-Guisa JM, Collins S, Febbraio M, Heinecke J, Eddy AA (2009) J Am Soc Nephrol 20(3): 495-505
    › Primary publication · 19211715 (PubMed) · PMC2653683 (PubMed Central)
  4. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury. Okamura DM, López-Guisa JM, Koelsch K, Collins S, Eddy AA (2007) Am J Physiol Renal Physiol 293(2): F575-85
    › Primary publication · 17537985 (PubMed)